The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).
 
Sara Nunnery
No Relationships to Disclose
 
Dorothy Wang
No Relationships to Disclose
 
Marisela Tan
No Relationships to Disclose
 
Richard Fong
Stock and Other Ownership Interests - Gilead Sciences; Juno Therapeutics
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
 
Mimi Ming Lo
No Relationships to Disclose
 
Rebecca L. Olin
Honoraria - Synapse
Consulting or Advisory Role - Jazz Pharmaceuticals (I)
Research Funding - Astellas Pharma; Clovis Oncology (I); Daiichi Sankyo; Genentech/Roche; Ignyta (I); MedImmune (I); Mirati Therapeutics (I); Novartis (I)